14th Annual USC Multi-Disciplinary Breast Cancer Symposium

Pre-registration ends January 12, 2027 at 12:00pm PST. To register after January 12, please register on-site.

This program will review the current state-of-the-art for breast cancer management, highlighting the key components of multi-disciplinary treatment to include oncofertility, breast pathology, surgical oncology, medical oncology, and radiation oncology. The format of this program will consist of lectures by internationally recognized clinical investigators in their fields.

Over the past year, advances in clinical trials have demonstrated the utility of antibody-drug conjugates, downstaging surgical management of the axilla, and the emergence of a new class of adjuvant endocrine therapy agents. These developments, along with data on use of hormone therapy after a breast cancer diagnosis, use of assisted reproductive technology to enhance pregnancy after breast cancer, and development of spatial ecosystems coupled with immunotherapy make individualized management decisions increasingly important in treating patients with breast cancer. Newer radiation therapy treatment strategies and clinical trials in radiation oncology continue to evolve. These breakthroughs allow personalized breast cancer treatments to maximize benefits and minimize treatment toxicities.

To update practicing physicians on the rapidly evolving landscape of breast cancer management, the symposium this year will focus on advances in endocrine therapy, in the adjuvant and metastatic setting, surgical management of the axilla, clinical trials in radiation therapy, oncofertility, the use of antibody drug conjugates, evolving strategies in HER2-positive breast cancer, and immunotherapy. Thought leaders and investigators in each of their respective fields have accepted our invitations to share their current research and knowledge.

1. Understand the latest developments in spatial ecosystems (neighborhoods) and their role in immunotherapy for breast cancer.
2. Assess the utility of assisted reproductive technologies to preserve ovarian function after treatment for breast cancer.
3. Discuss latest developments in use of antibody drug conjugates in the adjuvant, neoadjuvant, and metastatic settings.
4. Identify the controversies regarding the de-escalation of radiation therapy for invasive breast cancer.
5. Assess decision-making processes in surgical management of the axilla.
6. Define the role of endocrine therapy for early and metastatic breast cancer.

The Keck School of Medicine of the University of Southern California designates this Live Activity activity for a maximum of 7.50 AMA PRA Category 1 Credits™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Cancellation Policy

Cancellations must be received by the USC Office of CME by email only by January 12, 2026 at 12:00 pm PT for a refund. A $50 cancellation fee will be applied. In the event of course cancellation by conference organizers, all registration fees will be fully refunded. USC will not refund any travel costs incurred.


Accessibility Statement
 
Keck School of Medicine Healthcare System is committed to ensuring that its programs, services, goods and facilities are accessible to individuals with disabilities as specified under Section 504 of the Rehabilitation Act of 1973 and the Americans with Disabilities Amendments Act of 2008. If you have needs that require special accommodations, including dietary concerns, please contact the USC Office of CME at [email protected].

SLS Hotel, 465 S. La Cienega Boulevard, Los Angeles, CA 90048

Rate: $339, JJanuary 14, 2027 -January 17, 2027

For reservations, call (310) 247-0400 before January 5, 2027. Mention the USC Keck School of Medicine Symposium on January 16, 2027 for the discounted rate.

The Keck School of Medicine Healthcare System School of Medicine adheres to ACCME Criteria, Standards and Policies regarding industry support of continuing medical education. Disclosure of faculty and their commercial relationships will be made prior to the activity.

Mitigation of Relevant Financial Relationships

Keck School of Medicine Continuing Medical Education adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.

Member Information

Role in activity

Nature of Relationship(s) / Name of Ineligible Company(s)

Amir Ahari, MD
Dr
USC
Los Angeles , CA

Faculty

Batul Al-Zubeidy, MD
University of Southern California
Pasadena, CA

Faculty

Reva Basho, MD

Faculty

Azadeh Carr, MD
KSOM-Keck School of Medicine
Los Angeles, CA

Faculty

Eric L Chang, MD, FASTRO
Professor and Chair
Keck School of Medicine of USC
Los Angeles, CA

Faculty

Nothing to disclose

Aadel Chaudhuri, MD
, CA

Faculty

Charles E Geyer Jr., MD
Professor of Medicine
University of Pittsburgh Hillman Cancer Center
Mars, PA

Faculty

Armando E Giuliano, MD
Los Angeles, CA

Faculty

William Gradishar, MD
Northwestern University
Oak Park, IL

Faculty

Malynn Anne IIanga, MD

Faculty

Cecilia IM, MD

Faculty

Juliana M Kling , MD
Professor of Medicine
Mayo Clinic
Cave Creek , AZ

Faculty

Honoraria-Inflection (Relationship has ended)|Honoraria-AiCME (Relationship has ended)|Consulting Fee-Naviday (Relationship has ended)|Consulting Fee-Y Story (Relationship has ended)|Honoraria-Bayer (Relationship has ended)|Honoraria-EPG health (Relationship has ended)|Honoraria-Vindico Medical educaiton (Relationship has ended)|Honoraria-Elsevier (Relationship has ended)

Diane Ling, MD
USC
Los Angeles, CA

Faculty

Nothing to disclose

Nicholas P McAndrew, MD
Assistant Professor
UCLA
Los Angeles, CA

Faculty

Katherine E McDaniel, MD
Dr.
HRC Fertility/University of Southern California
Los Angeles, CA

Faculty

Monica Morrow, MD
Dr.
Memorial Sloan Kettering Cancer Center
New York, NY

Faculty

Evanthia Roussos Torres, MD
Dr.
University of Southern California- Norris Comprehensive Cancer Center
Los Angeles, CA

Faculty

Stephen F. Sener, MD
Chief of Surgery
LAGMC
Los Angeles, CA

Faculty

Nothing to disclose

David Wazer, MD

Faculty

Kendall Weierich, MD

Faculty

Jason C. Ye, MD
Keck School of Medicine of USC
Los Angeles, CA

Faculty

Saturday, January 16, 2027